- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04659850
Impact of AGEs on Metabolism & Cognition (AGEs)
Do Dietary AGEs Have an Acute Effect on Metabolism and Cognition
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
This study will be a short-term, randomized, double-blind, cross-over trial. Volunteers will be younger (18-30 years) and older (55-75 years) men and women, normal and overweight (BMI>19 to 29.9). N=24 in each age group.
Medical screening for all study volunteers and neuropsychological screening will be carried out prior to study start. A small, pin prick, fasted blood sample will be taken to measure glucose and HbA1C levels to rule out type 2 diabetics. Anthropometric and body composition measurements will also be taken. Body weight and height will be measured using a scale and a stadiometer to the nearest 0.5 kg and 0.5 cm, respectively. Waist and hip circumferences will be measured and the waist-to-hip ratio calculated. Standard procedures will be followed for the anthropometric measurements and the average of three measurements taken. Neuropsychological screening may be repeated on another day if volunteers are borderline on their first visit as scores may vary by a couple of points depending on external events i.e. vounteers are having a bad day. Experienced staff will carry out abdominal fat measurements by manual determination of the area between the upper surface of the second lumbar vertebra, the lower surface of the fourth lumbar vertebra, and the lateral margins of the outer rib cage. If the Viscan is available we will use that to measure abdominal fat. Venous blood samples will be collected as appropriate for the hormones and metabolites to be tested and stored at -70 °C.
The day prior to the challenge volunteers will visit the Human Nutrition Unit (HNU, RINH). They will be given a low AGE breakfast and be supplied with a low AGE lunch and dinner for that day and instructed not to consume anything else. After an overnight fast volunteers will receive a one-off dose of either high AGE (11.4 mgs) or low AGE (2.4 mgs) whey protein delivered in a either a low or high fat milkshake (400ml) blended with flavours and a consistent quantity of sugar. All ingredients will be commercially available and of food grade. Apart from differences in fat and AGE the content of shakes will be closely balanced for sugar and other components. All participants will be asked to answer two questionnaires one to determine their habitual intake of dietary AGEs and one to determine their level of physical activity.
The different milkshakes will be tested with a minimum 7 day wash out period between tests. Volunteers will be randomised to each test group. After a 12 h overnight fast and a standardised intake the day prior to the tests, and no strenuous physical activity for 2 days previously, subjects will attend the HNU. Volunteers will be requested to provide a small urine sample for AGE analysis. An intravenous catheter will then be placed in an antecubital vein and flushed with saline between aspirations to keep the catheter clear. After a short resting period, a blood sample will be taken prior to the first memory test then a single milkshake will be consumed under supervision. Blood samples will be taken immediately before the milkshake ingestion (0 min) and after 30, 60, 90, 120, 150 and 180 and 240 min. Further computer based memory tests will be carried out at 30, 90 and 240 minutes. A urine sample will be requested at the end of the study before participants are offered lunch. Memory tests have been designed by Dr Ros Langston (University of Dundee) and Dr Kevin Allan, School of Psychology and will be carried out on lap tops specifically designated for this study. Blood and urine will be analysed for AGEs. Blood will also be analysed for glucose lipids and hormones. Dr Janice Drew will also analyse blood samples for gene expression of the SIRT-1/NAD+ complex indicative of the response of individuals to dietary challenge.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Scotland
-
Aberdeen, Scotland, Vereinigtes Königreich, AB252ZD
- University of Aberdeen Rowett Institute of Nutrition and Health
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Heathy
- Sedentary
- 18-30 or
- 55-75
Exclusion Criteria:
- diagnosed type 2 diabetes,
- CVD
- history of neurological abnormalities
- current psycho-active medication
- current anti-inflammatory medication
- Current glucose lowering medication
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Crossover-Aufgabe
- Maskierung: Doppelt
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Sonstiges: Group 1
Group 1 participants in the young 18 - 30 age group
|
low fat, low AGE milkshake given after an overnight fast
low fat, high AGE milkshake given after an overnight fast
high fat, low AGE milkshake given after an overnight fast
high fat, high AGE milkshake given after an overnight fast
|
|
Sonstiges: Group 2
Group 2 participants in the older 55 - 75 age group
|
low fat, low AGE milkshake given after an overnight fast
low fat, high AGE milkshake given after an overnight fast
high fat, low AGE milkshake given after an overnight fast
high fat, high AGE milkshake given after an overnight fast
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Impact of Advanced Glycation End Products on Metabolism and Cognition
Zeitfenster: Four weeks per participant
|
Habitual AGE intake, determined from dietary questionnaires, specifically designed for this purpose, taken at the start of the study, will be correlated with levels of circulating AGEs and outcomes such as inflammatory markers and expression of genes associated with susceptibility to metabolic disease and acute response to dietary challenge will be measured.
|
Four weeks per participant
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Fiona Campbell, PHD, UoA Rowett Institute of Nutrition and Health
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 2017/RI/5
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Keine Bedingungen
-
University of FloridaEunice Kennedy Shriver National Institute of Child Health and Human Development...AbgeschlossenIndividuelle, Kategorie- und No-Label-BedingungenVereinigte Staaten
-
Heinrich-Heine University, DuesseldorfAbgeschlossenMononukleäre Zelle des peripheren Blutes | Rote Blutkörperchen | Endotheliale NO-SynthaseDeutschland
-
Ain Shams UniversityAbgeschlossen
-
TC Erciyes UniversityAbgeschlossen
-
Assiut UniversityNoch keine Rekrutierung
-
Charles River AnalyticsNational Institute on Drug Abuse (NIDA); Massachusetts General HospitalNoch keine RekrutierungKEIN VAPE + 12 Wochen Standard-CBT | Schein-NO-VAPE + 12 Wochen Standard-CBT
-
Hull University Teaching Hospitals NHS TrustAbgeschlossenSTEMI | Kein Reflow-PhänomenVereinigtes Königreich
-
Assiut UniversityAbgeschlossen
-
Second Affiliated Hospital, School of Medicine,...The Second Affiliated Hospital of Jiaxing University; Wenzhou People's Hospital und andere MitarbeiterNoch keine RekrutierungMyokardinfarkt mit ST-Hebung | No-Reflow-Phänomen
-
First Hospital of China Medical UniversityAstraZenecaUnbekanntHerzinfarkt | No-Reflow-PhänomenChina
Klinische Studien zur low fat, low AGE milkshake
-
Hvidovre University HospitalUniversity of Copenhagen; Danish Research Centre for Magnetic ResonanceAbgeschlossenDiabetes | Metabolisches Syndrom | NAFLD | Übergewicht und AdipositasDänemark
-
Centre Hospitalier Saint Joseph Saint Luc de LyonNoch keine RekrutierungNierenversagen, chronisch | Diät-Gewohnheit | Chronische Nierenerkrankung stage3 | Chronische Nierenerkrankung Stadium 3B | Chronische Nierenerkrankung, Stadium 3 (mäßig) | Chronische Nierenerkrankung Stadium 3A (Störung)Frankreich
-
Washington University School of MedicineAmerican Cancer Society, Inc.AbgeschlossenBrustkrebsVereinigte Staaten
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA)Abgeschlossen
-
University of BelgradeAbgeschlossen
-
Taipei Veterans General Hospital, TaiwanRekrutierung
-
Icahn School of Medicine at Mount SinaiNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)AbgeschlossenMetabolisches SyndromVereinigte Staaten
-
Marmara University Pendik Training and Research...Abgeschlossen
-
University of British ColumbiaUniversity of WollongongAbgeschlossen
-
Stanford UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RekrutierungFettleibigkeit | Diabetes mellitus, Typ 2 | Insulinresistenz | Prädiabetes | Ernährungsumstellung | Nichtalkoholische Stratohepatitis | Alkoholfreie FettleberVereinigte Staaten